Sökning: WFRF:(Tiensuu Janson Eva) >
Regulation of insul...
Regulation of insulin and glucagon secretion from rat pancreatic islets in vitro by somatostatin analogues
-
- Ludvigsen, Eva (författare)
- Uppsala universitet,Institutionen för medicinsk cellbiologi
-
- Stridsberg, Mats (författare)
- Uppsala universitet,Institutionen för medicinska vetenskaper,Klinisk kemi
-
- Taylor, John (författare)
- Biomeasure, Inc./Beaufour-IPSEN Group, Milford, PA, USA
-
visa fler...
-
- Culler, Michael (författare)
- Biomeasure, Inc./Beaufour-IPSEN Group, Milford, PA, USA
-
- Öberg, Kjell (författare)
- Uppsala universitet,Institutionen för medicinska vetenskaper,Onkologisk endokrinologi
-
- Janson, Eva Tiensuu (författare)
- Uppsala universitet,Institutionen för medicinska vetenskaper,Onkologisk endokrinologi
-
- Sandler, Stellan (författare)
- Uppsala universitet,Institutionen för medicinsk cellbiologi
-
visa färre...
-
(creator_code:org_t)
- Elsevier BV, 2007
- 2007
- Engelska.
-
Ingår i: Regulatory Peptides. - : Elsevier BV. - 0167-0115 .- 1873-1686. ; 138:1, s. 1-9
- Relaterad länk:
-
https://urn.kb.se/re...
-
visa fler...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Somatostatin is an inhibitor of hormone secretion through specific receptors (sst1-5). The aim of this study was to investigate the putative regulatory role of somatostatin analogues on the secretion of insulin and glucagon by rat pancreatic islets. After 48 h exposure only the non-selective agonists (somatostatin, octreotide and SOM-230) inhibited insulin accumulation. The inhibition of insulin secretion was accompanied by increased islet insulin contents. None of the analogues showed a consistent effect on the glucagon accumulation in the medium after 48 h. Since we observed a difference in the regulatory effect between the non-selective and selective analogues, combinations of selective analogues were studied. Combination of sst2 + sst5 agonists inhibited the medium insulin accumulation, while combination of sst1 + sst2 analogues caused a decrease in glucagon accumulation. After removal of somatostatin a rebound effect with increased insulin secretion were observed. This effect was reversed after 6 h. For SOM-230 insulin secretion continued to be suppressed even after the analogue was removed and returned to control values after 3 h. As for glucagon secretion there was an initial decline after culture with octreotide, while the other substances failed to induce any changes. In summary, non-selective somatostatin analogues or combinations of receptor selective analogues may cause inhibition of hormone secretion from rat pancreatic islets. For insulin and glucagon, combinations of sst2 + sst5 and sst1 + sst2, respectively may exert this effects. Thus, our data suggest that more than one sst must be involved to down-regulate islet glucagon and insulin secretion.
Nyckelord
- Glucagon secretion
- Insulin secretion
- Pancreatic islets
- Somatostatin analogues
- Somatostatin receptors
- MEDICINE
- MEDICIN
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas